Dogwood Therapeutics DWTX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $13.23M-24.6% | $6.52M-56.1% | $10.13M+396% | $13.4M+344% | $17.54M+637% | ||
| $1.78M+9.3% | $1.91M+12.4% | $1.53M+528% | $1.3M+111% | $1.62M+92.3% | ||
| $15M-21.7% | $8.43M-49.0% | $11.66M+410% | $14.7M+304% | $19.16M+494% | ||
| $12.54K-21.1% | $12.75K-24.1% | $15.29K— | $16.18K— | $15.9K— | ||
| $146.75K-24.3% | $163.14K-20.7% | $174.01K— | $190.96K— | $193.76K— | ||
| $12.19M+3.1% | $12.4M+5.0% | $12.21M— | $12.46M— | $11.82M— | ||
| $67.83M+3.1% | $68.99M+5.0% | $67.92M— | $69.3M— | $65.77M— | ||
| $11.91M+3.4% | $12.11M+7.0% | $11.89M— | $12.13M— | $11.52M— | ||
| $95.21M-1.8% | $90.17M-4.4% | $91.99M+3,929% | $96.69M+2,559% | $96.98M+2,908% | ||
| $144.4K-87.5% | $760.95K-38.2% | $584.6K+28.5% | $498.12K+129% | $1.15M+486% | ||
| $2.35M+70.8% | $2.24M+18.3% | $1.96M+123% | $1.33M+372% | $1.38M+268% | ||
| $57.31K+13.0% | $56.84K+14.4% | $54.57K— | $54.5K— | $50.72K— | ||
| $2.56M-0.8% | $3.06M-3.7% | $2.6M+94.7% | $1.89M+277% | $2.58M+353% | ||
| $87.62K-37.7% | $105.76K-31.7% | $120.21K— | $132.49K— | $140.53K— | ||
| $144.93K-24.2% | $162.6K-20.5% | $174.78K— | $186.99K— | $191.24K— | ||
| $14.58M+2.5% | $15.27M-49.1% | $14.61M+995% | $14.15M+2,730% | $14.24M+2,397% | ||
| $3.34K+1,649% | $2.97K+2,136% | $229+106% | $191-93.1% | $191-90.1% | ||
| $195.7M+176% | $183.86M+171% | $73.16M+8.6% | $71M+5.6% | $70.94M+8.0% | ||
| -$113.06M-33.4% | -$108.08M-46.4% | -$104.3M-57.8% | -$88.55M-38.8% | -$84.74M-35.0% | ||
| -$1.72M+54.7% | -$587.04K+84.8% | -$1.64M— | -$267.29K— | -$3.8M— | ||
| $299.13K0.0% | $299.13K0.0% | $299.13K0.0% | $299.13K0.0% | $299.13K0.0% | ||
| $80.62M+1,038% | $74.9M+840% | $7.26M+664% | $6.88M+119% | $7.09M+167% | ||
| $95.21M-1.8% | $90.17M-4.4% | $91.99M+3,929% | $96.69M+2,559% | $96.98M+2,908% | ||
| $146.75K-24.3% | $163.14K-20.7% | $174.01K— | $190.96K— | $193.76K— | ||
| $67.83M+3.1% | $68.99M+5.0% | $67.92M— | $69.3M— | $65.77M— | ||
| $146.75K-24.3% | $163.14K-20.7% | $174.01K— | $190.96K— | $193.76K— | ||
| $146.75K-24.3% | $163.14K-20.7% | $174.01K— | $190.96K— | $193.76K— | ||
| $2.35M+70.8% | $2.24M+18.3% | $1.96M+123% | $1.33M+372% | $1.38M+268% | ||
| $2.35M+70.8% | $2.24M+18.3% | $1.96M+123% | $1.33M+372% | $1.38M+268% | ||
| $9.57K— | —— | —— | —— | —— | ||
| $144.93K-24.2% | $162.6K-20.5% | $174.78K— | $186.99K— | $191.24K— | ||
| $3.34K+1,649% | $2.97K+2,136% | $229+106% | $191-93.1% | $191-90.1% | ||
| $80.92M+996% | $75.2M+865% | $7.56M+505% | $7.18M+109% | $7.39M+150% | ||
| $159K— | $158.96K— | —— | —— | —— | ||
| $11.91M+3.4% | $12.11M+7.0% | $11.89M— | $12.13M— | $11.52M— | ||
| $28.72K— | —— | —— | —— | —— | ||
| $18.72K+3.1% | $19.04K+5.0% | $18.74K— | $19.13K— | $18.15K— | ||
| $80.92M+996% | $75.2M+865% | $7.56M+505% | $7.18M+109% | $7.39M+150% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Dogwood Therapeutics's total assets?
- Dogwood Therapeutics (DWTX) holds $95.2M in total assets, down 1.8% year over year.
- How much debt does Dogwood Therapeutics have?
- Dogwood Therapeutics carries $144.9K in total debt against $80.6M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Dogwood Therapeutics have?
- Dogwood Therapeutics holds $13.2M in cash and equivalents.
- Can Dogwood Therapeutics cover its short-term obligations?
- Its current ratio is 5.86 — current assets exceed current liabilities.
- Where does Dogwood Therapeutics's balance sheet data come from?
- Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.